LIFE HEALTHCARE GROUP HOLDINGS UNSPON ADR EA REPR 4 ORD ZAR0.00
LTGHY
Halozyme Therapeutics
HALO
AIRPORTS OF THAILAND PUBLIC CO UNSP ADR EACH REP 10 ORD SHS
AIPUY
YETI Holdings
YETI
Dorian LPG
LPG
(Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating cash flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 21.15%1.64B | 397.06%1.35B | 28.82%219M | |||||||
Net income from continuing operations | ---- | ---- | ---- | 68.36%729M | ---- | ---- | ---- | ---- | -86.17%433M | ---- |
Operating gains losses | ---- | ---- | ---- | -115.84%-125M | ---- | ---- | ---- | ---- | 129.51%789M | ---- |
Deferred tax | ---- | ---- | ---- | -2,166.67%-62M | ---- | ---- | ---- | ---- | -99.27%3M | ---- |
Other non cash items | ---- | ---- | ---- | 46.15%209M | ---- | ---- | ---- | ---- | 139.07%143M | ---- |
Change in working capital | ---- | ---- | ---- | 817.92%761M | ---- | ---- | ---- | ---- | 66.56%-106M | ---- |
-Change in receivables | ---- | ---- | ---- | 749.25%569M | ---- | ---- | ---- | ---- | 104.67%67M | ---- |
-Change in deferred acquisition costs | ---- | ---- | ---- | -8.87%113M | ---- | ---- | ---- | ---- | -64.87%124M | ---- |
-Change in accrued investment income | ---- | ---- | ---- | -19.29%272M | ---- | ---- | ---- | ---- | -59.25%337M | ---- |
-Change in payables and accrued expense | ---- | ---- | ---- | 65.95%-95M | ---- | ---- | ---- | ---- | -140.43%-279M | ---- |
-Change in other working capital | ---- | ---- | ---- | 72.39%-98M | ---- | ---- | ---- | ---- | 52.86%-355M | ---- |
Cash from discontinued operating activities | 0 | 0 | ||||||||
Operating cash flow | 78.41%719M | -55.80%316M | 48.08%231M | 21.15%1.64B | 66.21%364M | -3.59%403M | 102.55%715M | -56.91%156M | 6,045.45%1.35B | 28.82%219M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | -213.02%-486M | -111.54%-92M | 129.24%1.08B | 230.11%2.53B | 833M | 215.59%430M | 168.06%797M | 217.12%472M | -142.34%-1.95B | 0 |
Net investment purchase and sale | -149.54%-160M | -71.10%204M | -13.71%875M | 537.23%2.88B | 22.11%834M | 189.97%323M | 196.45%706M | 505.60%1.01B | 29.78%-658M | 509.82%683M |
Net proceeds payment for loan | 1,825.00%138M | 595.00%99M | 0.00%99M | 3.78%192M | 427.03%121M | -214.29%-8M | -116.26%-20M | 7.61%99M | 2,212.50%185M | -37.04%-37M |
Net business purchase and sale | -2,592.86%-377M | -545.31%-413M | 92.67%-47M | 56.93%-684M | 106.57%35M | 90.97%-14M | 90.00%-64M | -146.54%-641M | -240.04%-1.59B | -0.57%-533M |
Net other investing changes | -167.44%-87M | --18M | --155M | 27.83%147M | -38.94%-157M | -4.44%129M | ---- | ---- | -80.61%115M | -232.94%-113M |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | -213.02%-486M | -111.54%-92M | 129.24%1.08B | 230.11%2.53B | --833M | 215.59%430M | 168.06%797M | 217.12%472M | -495.11%-1.95B | --0 |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 110.43%132M | 77.71%-220M | -54.75%-1.26B | -14,596.43%-4.06B | -577.55%-996M | -743.33%-1.27B | -234.84%-987M | -99.26%-811M | 110.57%28M | -167.27%-147M |
Net issuance payments of debt | 294.95%425M | 114.19%21M | -64.41%21M | -206.97%-353M | 48.89%-46M | -1,353.33%-218M | -159.68%-148M | -68.45%59M | 246.02%330M | 77.10%-90M |
Net common stock issuance | -238.00%-169M | -8.64%-176M | ---169M | 50.34%-369M | ---157M | -1,100.00%-50M | 35.20%-162M | --0 | 33.00%-743M | --0 |
Cash dividends paid | -7.14%-60M | -74.07%-47M | -70.59%-58M | -36.97%-163M | -91.67%-46M | -55.56%-56M | -12.50%-27M | 2.86%-34M | -2.59%-119M | 4.00%-24M |
Net other financing charges | 93.20%-64M | 97.23%-18M | -25.48%-1.05B | -666.79%-3.17B | -2,163.64%-747M | -804.81%-941M | -185.75%-650M | -1,270.49%-836M | -52.78%560M | -104.90%-33M |
Cash from discontinued financing activities | 0 | 0 | ||||||||
Financing cash flow | 110.43%132M | 77.71%-220M | -54.75%-1.26B | -14,596.43%-4.06B | -577.55%-996M | -743.33%-1.27B | -234.84%-987M | -99.26%-811M | 110.57%28M | -167.27%-147M |
Net cash flow | ||||||||||
Beginning cash position | -12.53%1.18B | 42.72%1.18B | 11.02%1.12B | -35.98%1.01B | -1.93%917M | 29.84%1.35B | -26.76%824M | -35.98%1.01B | -26.60%1.57B | -48.57%935M |
Current changes in cash | 184.49%365M | -99.24%4M | 131.69%58M | 119.61%111M | 179.17%201M | -315.38%-432M | 710.47%525M | 59.15%-183M | 0.70%-566M | 129.39%72M |
End cash position | 68.48%1.55B | -12.53%1.18B | 42.72%1.18B | 11.02%1.12B | 11.02%1.12B | -1.93%917M | 29.84%1.35B | -26.76%824M | -35.98%1.01B | -35.98%1.01B |
Free cash flow | 78.41%719M | -55.80%316M | 48.08%231M | 21.15%1.64B | 66.21%364M | -3.59%403M | 102.55%715M | -56.91%156M | 6,045.45%1.35B | 28.82%219M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | -- | -- |